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Abstract
The polysaccharide capsule of Streptococcus pneumoniae is the main virulence
factor making the bacterium resistant to phagocytosis. The galU gene of
S. pneumoniae encodes a UDP-glucose pyrophosphorylase absolutely required
for capsule biosynthesis. In silico analyses indicated that the galU gene is
co-transcribed with the gpdA gene, and four putative promoter regions located
upstream of gpdA were predicted. One of them behaved as a functional pro-
moter in a promoter reporter system. It is conceivable that the sequence
responsible for initiating transcription of gpdA-galU operon is an extended
10 site TATGATA(T/G)AAT. Semi-quantitative real-time reverse transcrip-
tion PCR experiments indicated that galU was expressed mainly in the expo-
nential phase of growth.
Introduction
Streptococcus pneumoniae is a leading human pathogen
causing both mucosal (such as otitis media and pneumo-
nia) and systemic diseases (including septicemia and
meningitis). To date, 93 different pneumococcal capsular
types have been described (Henrichsen, 1995; Park et al.,
2007; Bratcher et al., 2010; Calix & Nahm, 2010). This
remarkable phenotypic variability appears to be present
also at the genetic level (Bentley et al., 2006). Early stud-
ies showed that uridine diphosphoglucose (UDP-Glc) is a
key component in the biosynthetic pathway of pneumo-
coccal capsular polysaccharides containing glucose, galac-
tose, and/or UDP-glucuronic or UDP-galacturonic acids
(Mills & Smith, 1965). At least one of these sugars is a
component of every capsular polysaccharide of S. pneu-
moniae (Kamerling, 2000). The enzyme UTP-Glc-1-phos-
phate uridylyltransferase (UDP-Glc pyrophosphorylase;
EC 2.7.7.9) is encoded by the galU gene. This enzyme
catalyzes the formation of UDP-Glc, which is the sub-
strate for the synthesis of UDP-glucuronic acid. Also,
UDP-Glc is also required for the interconversion of
galactose and glucose by way of the Leloir pathway (Frey,
1996).
Previously, the galU gene was cloned and overexpres-
sed, and the gene product was biochemically character-
ized (Mollerach et al., 1998; Bonofiglio et al., 2005). In
addition, knockout galU mutants of type 1 and type 3
pneumococci are unable to synthesize a detectable capsu-
lar polysaccharide. Southern blot hybridization experi-
ments using DNAs prepared from pneumococcal isolates
belonging to different types showed that every strain
tested contained a galU homologue (Mollerach et al.,
1998). Thus, the UDP-Glc pyrophosphorylase, which is
directly involved in the synthesis of the capsular polysac-
charide in S. pneumoniae, might represent a suitable
target in the search for inhibitors to control the biosyn-
thesis of the main pneumococcal virulence factor. In this
sense, it should be emphasized that eukaryotic UDP-Glc
pyrophosphorylases appear to be completely unrelated to
their bacterial counterparts, suggesting the possibility that
putative inhibitors of the bacterial enzymes would not be
harmful for the host.
The gpdA gene (also named gpsA) is located immedi-
ately upstream of the galU gene and is predicted to
encode a glycerol-3-phosphate dehydrogenase [NAD(P)
(+)], (EC 1.1.1.94). The spr1901 gene, which is annotated
as a possible transcriptional regulator, is located upstream
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of the gpdA gene and transcribed from the opposite
strand. Nothing is known about the promoter region of
galU and its differential expression at different growth
phases. In this report, we identified a promoter-active
DNA sequence from S. pneumoniae located upstream of
gpdA that is involved in controlling the expression of
galU through co-transcription with gpdA. These findings
provide insight into the expression of GalU, an enzyme
with a key role in virulence.
Materials and methods
Bacterial strains and growth conditions
Streptococcus pneumoniae 406 and M31 were grown in
liquid C medium (Lacks & Hotchkiss, 1960) supple-
mented with 0.08% of each yeast extract (CY medium)
and bovine serum albumin without shaking, or on recon-
stituted tryptose blood agar base plates (Difco Laborato-
ries Inc., Detroit, MI) supplemented with 5% defibrinated
sheep blood. Lincomycin (0.6 lg mL1) was added when
required. Streptococcus pneumoniae M31 (DlytA) is a non-
encapsulated, serotype 2 (S2) mutant having a deletion
of at least 5.5 kb containing the gene lytA that encodes
the main pneumococcal autolysin (Sa´nchez-Puelles et al.,
1986). Streptococcus pneumoniae 406 is a clinical isolate of
serotype 3 (Garcı´a et al., 1993).
Escherchia coli C600 cells (thi-1, leuB, thr-1) were
grown in Luria–Bertani growth medium (LB) at 37 °C or
on LB solid agar supplemented when necessary with
tetracycline (20 lg mL1; Sambrook et al., 1989).
DNA techniques and plasmid construction
Restriction enzymes, T4 DNA ligase and the Klenow frag-
ment of DNA polymerase were obtained commercially
and used according to the recommendations of the sup-
pliers. Chromosomal DNA from S. pneumoniae 406 was
prepared as previously described (Fenoll et al., 1994; Wil-
son, 1997). PCR was performed using standard condi-
tions with AmpliTaq DNA polymerase (PerkinElmer).
The primers used are listed in Table 1. An SphI/BbuI
restriction site was included in oligonucleotides pGalU1,
pGalU3, pGalU5, and pGalU7 and an SmaI restriction
site in pGalU2, pGalU4, pGalU6, and pGalU8. Four dif-
ferent DNA fragments (F1–F4), one overhanging the
other and containing putative promoter regions, were
amplified by PCR.
Plasmid pLSE4 is a promoter probe vector able to repli-
cate in S. pneumoniae and E. coli that contains a promo-
terless lytA gene (Dı´az & Garcı´a, 1990). DNA fragments
were ligated separately on pLSE4 previously digested with
XbaI, filled with Klenow fragment and digested with BbuI.
Transformation procedures
Escherichia coli C600 was made competent and transformed
with derivatives of pLSE4 as described elsewhere (Mun˜oz
et al., 1997). The accuracy of the constructs was confirmed
by nucleotide sequencing of the corresponding insert.
Plasmid derivatives of pLSE4 containing DNA fragments
(F1–F4) were transformed into S. pneumoniae M31.
Streptococcus pneumoniae was transformed with plasmid
DNA by treating cells in C medium supplemented with
0.08% of bovine serum albumin with synthetic compe-
tence-stimulating pheromone (250 ng mL1) at 37 °C for
10 min to induce competence (Moscoso & Claverys,
2004) followed by incubation at 30 °C during DNA
uptake. Streptococcus pneumoniae clones obtained upon
transformation with derivatives of pLSE4 were scored on
CY agar plates containing lincomycin (0.6 lg mL1) and
catalase (250 units mL1).
Assay for lytic activity
Crude sonicated extracts were obtained as previously
described from mid-exponentially growing cultures for
S. pneumoniae M31 derivatives (Ronda et al., 1987).
Assays of cell wall lytic (N-acetylmuramoyl-L-alanine ami-
dase; NAM-amidase) activity were performed according
to standard procedures described elsewhere using
[methyl-3H]choline-labeled pneumococcal cell walls as
substrate (Ho¨ltje & Tomasz, 1976). One unit of NAM-
amidase activity was defined as the amount of enzyme
needed to catalyze the hydrolysis (solubilization) of 1 lg
of cell wall material in 10 min at 37 °C.
RNA isolation, cDNA synthesis, and RT-PCR
Total RNA was extracted from S. pneumoniae cultures in
CY medium using the RNeasy mini Kit (QIAGEN). Cells
were harvested throughout the growth curve at 37 °C
(A550 nm of 0.12, 0.33, 0.67, and 0.66 that corresponds
respectively to early, medium logarithmic, late logarithmic,
and stationary growth phase) and stored in ice. Pellets were
resuspended in 0.9% NaCl solution and stored at 80 °C.
The concentration and the purity were estimated using an
ND1000 Spectrophotometer (Nanodrop Technologies).
Primers used for qRT-PCR are listed in Table 1.
cDNA was synthesized using SuperScript II Reverse
Transcriptase (Invitrogen), according to the manufac-
turer’s protocol. To ensure that the amplification
observed in the PCRs was attributable to the cDNA tem-
plate made from mRNA and not from contaminating
genomic DNA, controls were carried out for each sample
under the same conditions, except that transcriptase was
not added to the reactions. Semi-quantitative real-time
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PCR (RT-PCR) experiments were performed using SYBR
Green technology in an ABI Prism 7000 Sequence Detec-
tion System (Applied Biosystems). Each experiment was
carried out in triplicate, so each relative gene expression
reported for each point of the curve represents the aver-
age of three independent biologic replicates. Changes in
sample gene expression were measured based on an exter-
nal standard used as a calibrator (Wong & Medrano,
2005). Dunnet’s test was used to determine whether the
expression values of a given point were significantly
different from other points of the curve.
Genome analysis and multiple-sequence
alignments
Sequences of S. pneumoniae genomes were retrieved from
the NIH GenBank database (http://www.ncbi.nlm.nih.gov/
genome?term=streptococcus%20pneumoniae). Multiple-
sequence alignments were performed using the CLUSTALW2
program (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Results and discussion
In silico analysis indicates that galU and gpdA
genes are co-transcribed
The analysis of the 23 S. pneumoniae genomic complete
sequences available at the NIH website (http://www.ncbi.
nlm.nih.gov/genome?term=streptococcus%20pneumoniae)
revealed that galU and gpdA are adjacent and in the same
orientation in the S. pneumoniae chromosome. Transcrip-
tional terminator prediction was made using Trans-
TermHP (http://transterm.cbcb.umd.edu/index.php).
TransTermHP was run on seven complete S. pneumoniae
genomes currently available at this site. The search process
indicates that no terminator is present after gpdA gene
although a rho-independent transcriptional terminator was
found downstream of galU. In the case of S. pneumoniae
R6, a predicted terminator was found with a confidence
value of 70, which is regarded as high (Kingsford et al.,
2007).
The gpdA and galU genes are located together and are
transcribed from the same DNA strand in 61 different
genomes belonging to the Firmicutes phylum. However,
the galU gene and its flanking regions do not have the
same organization in other bacterial species not closely
related to S. pneumoniae (Varo´n et al., 1993; Dean &
Goldberg, 2002; Silva et al., 2005).
Identification of a functional gpdA-galU
promoter region
Promoter prediction on the 827-bp sequence upstream of
the gpdA gene was carried out using the Neural Network
Promoter Prediction program (http://www.fruitfly.org/
seq_tools/promoter.html). Four sequences were detected
by this program as putative promoters with a score of at
least 0.88 (Fig. 1).
To determine whether the proposed promoter sequences
actually represent a gpdA-galU promoter, three DNA frag-
ments, one overhanging the other (F1, F3, and F4) and
containing the putative promoters, were PCR-amplified. A
1030-bp DNA fragment (F2) containing full-length gpdA
gene was also amplified to explore the existence of a pro-
moter region within this gene. After digestion with the
appropriate restriction enzymes, the DNA fragments were
ligated to the promoter probe vector pLSE4 previously
treated with the same enzymes and used to transform com-
petent cells of E. coli C600. The recombinant plasmids were
transferred to pneumococcal M31 strain (DlytA). Lincomy-
cin-resistant M31 transformants, harboring different
recombinant plasmids designated pMMP1 to pMMP4,
were obtained. Streptococcus pneumoniae M31 harboring
pMMP1 lysed at the end of the exponential phase of
growth (Fig. 2). Moreover, a detectable LytA amidase
activity (7.4 U mg1 of protein) was found in sonicated
extracts prepared from M31 harboring pMMP1, indicating
the existence of a functional promoter in the F1 fragment.
Table 1. Oligonucleotide primers used in this study
Primer name Nucleotide sequence (5′-3′)* Purpose on use Position†
pGalU1 AGGCATGCAAGTGCAAAATCCC Cloning F1 585–606
pGalU2 TTGCCCGGGAAGATTTCCCCAA Cloning F1 767–746
pGalU3 AAGCATGCAAAAACAAACCGTCGCCGT Cloning F2 650–676
pGalU4 TATCCCGGGTTAAGACCACTCATT Cloning F2 1679–1656
pGalU5 CTCGCATGCTACAAGAACTTCCTG Cloning F3 436–459
pGalU6 TTGCCCGGGCATTACTGGGGTAT Cloning F3 600–578
pGalU7 TTAAGCATGCTCACCAGAAGGACAGTA Cloning F4 –8–18
pGalU8 CAACCCGGGAGGTTCTTGTAGGTTG Cloning F4 464–440
galurtcD CCACGCGGTCTCGGAGAT RT-PCR 2010–2027
galurtcR GTTGTTTGGTAAGTGGAACA RT-PCR 2136–2117
*Bold-faced letters indicate nucleotides introduced to construct the appropriate restriction sites.
†Position is given relative to the last nucleotide of spr1901 (see Fig. 1).
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M31 cells containing pMMP2 also exhibited lysis at the
end of exponential phase of growth although with a rate
three times lower than that of the pMMP1 derivative.
Moreover, LytA amidase activity was undetectable in son-
icated extracts of this strain. By contrast, strains contain-
ing pMMP3, and pMMP4 and the promoterless vector
(pLSE4), did not show any lysis (Fig. 2).
Sequence analysis of the region upstream
gpdA-galU
The region located immediately upstream of gpdA is
highly conserved in pneumococcal genomes (Fig. 3a) and
was searched for the presence of promoter-like sequences.
A consensus, 10 extended promoter (TATGATATAAT;
Sabelnikov et al., 1995) was identified in the six pneumo-
coccal strains, and its single-nucleotide variant TAT
GATAgAAT was found in the rest of the 23 genome
sequences analyzed. Changes in this nucleotide are not
critical for the binding of the r subunit of the RNA poly-
merase (Sevostyanova et al., 2007). A Shine- and Dal-
garno-like sequence (SD) (AGGAGG) is located five
nucleotides upstream of the gpdA start codon (AUG). As
expected, the polycistronic transcript has a putative tran-
scription start site within a purine (A) nucleotide located
seven nucleotides downstream of the 10 extended pro-
moter element. The putative promoter sequence consists
of an extended 10 element without a 35 site and is
situated 30 nucleotides upstream of the ATG initiation
codon of the gpdA gene.
Regarding pneumococcal promoters, we compared sim-
ilar extended 10 elements of sulA (dihydropteroate syn-
thase), murB (UDP-N-acetylenolpyruvoylglucosamine
reductase), pcrA (ATP-dependent DNA helicase), comCDE
operon, and fcsR (regulator of fucose operon) with the
gpdA-galU promoter described herein (Chan et al., 2003;
Ware et al., 2005; Ruiz-Maso´ et al., 2006 and Martin
et al., 2010). These sequences match the consensus
extended 10 region previously described by Sabelnikov
et al. (1995) (TnTGnTATAAT). The nucleotides in the
canonical 10 hexamer TATAAT are conserved in murB,
pcrA, comCDE, fcsR, and gpdA-galU (six strains). More-
over, 10 extended promoter element of comCDE
showed an alteration of the T-TG extension. Also, 10
and 35 promoter elements found in fcsK (fuculose
kinase), yefM-yoeB (toxin–antitoxin), relB2 (antitoxin),
and tts (bglucosyltransferase) genes were compared, and
most of them showed 10 canonical element (TATAAT)
and the 35 box (TTGACA) with minor differences
(Llull et al., 2001; Chan et al., 2003, 2011; Nieto et al.,
2006). On the other hand, ung (DNA-uracil glycosylase)
(a)
(b)
Fig. 1. (a) Map of the 2.589-kb region containing the galU gene and putative promoters predicted by NNPP software (cut off > 0.88) (A–D).
Numbers in brackets indicate the nucleotide positions corresponding to the sequence included in the GenBank database under accession number
AE007317.1. Fragments F1–F4 were cloned in pLSE4 reporter plasmid generating pMMP1 to pMMP4 derivatives. (b) Putative promoter
sequences (A–D). Putative starting point of each sequence is bold-faced.
Fig. 2. (a) Functional characterization of gpdA-galU promoters. (a)
Growth and lysis curves of Streptococcus pneumoniae M31 (ΔlytA)
strain harboring plasmids pLSE4, pMMP1, pMMP2 pMMP3, or
pMMP4. (b) Pneumococcal cell wall hydrolyzing activity of cell
extracts obtained by sonication.
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and spxB (pyruvate oxidase) exhibit 10 extended pro-
moter element and a 35 box (Ramos-Montan˜ez et al.,
2008; Ruiz-Cruz et al., 2010), (Fig. 3b).
Expression of the galU gene is higher during
exponential phase
Semi-quantitative real-time reverse transcription PCR
(RT-PCR) was used to compare relative transcriptional
abundance of galU transcripts at different points of the
growth curve of S. pneumoniae R6. The results showed
that galU-specific transcript levels in the exponential
phase were 14-fold higher than during the other phases
(Dunnet’s test, P < 0.05; Table 2), in agreement with that
previously suggested for metabolic genes involved in bio-
synthetic processes whose expression is probably down-
regulated in the stationary phase (Navarro Llorens et al.,
2010). However, our results contrast with those carried




Fig. 3. (a) Multiple-sequence alignment of gpdA-galU promoter region from Streptococcus pneumoniae complete genome sequences deposited
in databases. (b) Promoter regions of different pneumococcal genes are shown. sulA, murB, pcrA, comCDE, and fcsR genes have proven 10
extended elements; fcsK, yefM-yoefB, relB2, tts genes present 10 and 35 elements; ung and spxB exhibit 10 extended and 35 elements.
Extended 10 sites, canonical 10 and 35 boxes are underlined. Conserved nucleotides are bold-faced. The consensus promoter sequence
described by Sabelnikov is given: TnTGnTATAAT. The numbers of nucleotides that are not showed in yefM-yoefB and spxB genes are indicated in
brackets. The sequences of the genes were taken from references cited in the text.
Table 2. Relative expression of galU gene of Streptococcus














2.4 ± 0.26 2.1 ± 0.32 2.6 ± 0.56 0.17 ± 0.06
qRT-PCR analysis was used to determine galU transcript abundance at
different time points during growth. The transcription data are the
means ± standard deviations of three independent experiments.
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casei (Wu et al., 2009) where the expression of the corre-
sponding galU genes increased in the stationary phase.
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